LIVED EXPERIENCE with SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD) Uncommon condition more prevalent in younger women
with
Jen O’Neill, Patient &
Board Member
SCAD Research Australia Inc &
Social Worker, Central Coast, NSW
LIVED EXPERIENCE SEGMENT
Filmed in Sydney | June 2026
Jen O’Neill is a Social Work Program Manager and mother of two from the Central Coast, NSW.
At 36, she experienced her first spontaneous coronary artery dissection (SCAD) heart attack and has since survived two further SCADs before age 43.
Her lived experience has driven a strong commitment to heart health advocacy, focusing on improving education, research, and clinical understanding of cardiovascular disease in women without typical risk factors.
Jen is a board member of SCAD Research Australia and serves on the Women’s Health Program Consumer Panel at The George Institute for Global Health.
She is an ambassador for Heart Research Australia’s Red Feb campaign and participates in studies including with the Victor Chang Cardiac Research Institute and Mayo Clinic.
She also supports community fundraising initiatives, including the Central Coast SCADaddle for Research Walk. She is recognised for leadership in advocacy and advancing cardiovascular health informed by lived experience.
Source: MTAA Women’s Health MedTech Summit program
Media access credit: Medical Technology Association of Australia (MTAA)
You Might also like
-
Evolution in consumer diagnostics with saliva based pathology
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
-
Medical research institutes association responds to draft national research strategy
On 27 August 2025, the Minister for Health, Disability and Ageing announced the release of the draft National Health and Medical Research Strategy (the National Strategy).
Involved in the initial consultation phase, was the Association of Australian Medical Research Institutes (AAMRI), the peak body for medical research institutes across Australia. Member institutes work on a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings.
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.